Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testim Gel plus tadalafil for erectile dysfunction in men with low or borderline testosterone
2005-005060-92Phase 3Terminated
- Sponsor
- Ipsen
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) and Hypoandrogenism (TD) comparing Testim + Cialis with Placebo gel + Cialis (2 arms). Primary endpoint: IIEF intercourse success response at week 12 or endpoint. Started May 2006; status: terminated.
02
Drugs
testosteronetadalafil
03
Conditions
erectile dysfunction (ED)Hypoandrogenism (TD)
Beyond the preview
Go deeper on 2005-005060-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005060-92.